Search results for "urinary tract infection"

showing 10 items of 46 documents

Holmium Laser Endoureterotomy With the Lovaco Technique for the Treatment of Ureterointestinal Stenosis: Step by step.

2018

Abstract Objective To describe holmium laser endoureterotomy with the Lovaco technique for the treatment of ureterointestinal stenosis. This common problem after cystectomy represents a surgical challenge, with endourological techniques being useful in this context. We present a technique that has been described before, but which we consider useful and decisive. The key points and difficult aspects of the technique are shown, along with our experience with it. Methods We collected data on cases of ureterointestinal stenosis treated using holmium laser endoureterotomy with the Lovaco technique, in a prospective manner, between January 2017 and January 2018. Intraoperative data, postoperative…

medicine.medical_specialtybusiness.industryFebrile urinary tract infectionUrologymedicine.medical_treatmentHolmium laserContext (language use)After dischargemedicine.diseaseSurgeryCystectomyStenosisMale patientMedicinebusinessUrology
researchProduct

Purple urine bag syndrome in an elderly subject

2012

strain. Given the absence of bothclinical signs (apart from urinary retention) and inflamma-tory syndrome, no antibiotic therapy was initiated. Six daysafterinsertingtheindwellingcatheter,purplecolorationoftheurine bag and the catheter appeared, with no modifications ofurine color (Fig. 1). Another urine microscopy and culture per-formedlongaftercatheterwithdrawal,showeddisappearanceof the

Microbiology (medical)medicine.medical_specialtymedicine.medical_treatmentlcsh:QR1-502ColorGastroenterologylcsh:MicrobiologyUrinary catheterizationUrine microscopylcsh:Infectious and parasitic diseasesPurple urine bag syndromeInternal medicineAntibiotic therapymedicineHumanslcsh:RC109-216Escherichia coli InfectionsMedicine(all)Aged 80 and overUrinary retentionbusiness.industrySyndromeSurgeryCatheterInfectious DiseasesUrinary Tract InfectionsFemalemedicine.symptomUrinary Catheterizationbusiness
researchProduct

Pathogenic factors in recurrent urinary tract infections and renal scar formation in children

1986

MalePathologymedicine.medical_specialtybusiness.industryUrinary systemInfantHost factorsCicatrixRecurrenceUrinary Tract InfectionsPediatrics Perinatology and Child HealthRenal scarsmedicineRenal scarHumansFemaleKidney DiseasesChildbusinessEuropean Journal of Pediatrics
researchProduct

Gas-containing renal stones: a red flag for renal infection.

2022

Background Gas in the renal excretory system is described as a consequence of recent procedures but it can be a sign of severe conditions such as fistulas or infections; however, gas-containing renal stones are only rarely encountered. Purpose To describe the association of gas-containing renal stones and urinary tract infection. Material and Methods We performed a retrospective evaluation of the clinical and imaging findings in a series of six patients with gas-containing renal stones and compared our findings with those of patients with gas-containing renal stones reported in the literature. Urine and stone cultures were used as a diagnostic standard for urinary tract infection. Results I…

medicine.medical_specialtyUrinary systemUrologyComputed tomographyUrineKidneyRenal infectionKidney CalculimedicineDIAGNOSTIC STANDARDHumansRadiology Nuclear Medicine and imagingRetrospective StudiesKidneyRadiological and Ultrasound Technologymedicine.diagnostic_testbusiness.industrycomputed tomographyGeneral Medicinerenal stonemedicine.anatomical_structureExcretory systemKidney; computed tomography; renal stone; urinary tract infectionUrinary Tract InfectionsFLAG (chemotherapy)businessurinary tract infectionActa radiologica (Stockholm, Sweden : 1987)
researchProduct

Influence of inadequate antimicrobial therapy on prognosis in elderly patients with severe urinary tract infections.

2013

Abstract Background Inadequate empirical antimicrobial therapy (IEAT) in intensive care unit (ICU) is associated with adverse outcomes. However, the influence of IEAT on prognosis for elderly patients with urinary tract infection (UTI) in non-ICU settings is unknown. Methods A retrospective cross-sectional study of elderly patients admitted to a non-ICU ward in a university hospital with a primary diagnosis of UTI over a 3-year period was done. Data relating to age, sex, background comorbidities, severity of infection, bacteremia, microorganisms isolated in urine, treatment given, length of stay and prognosis were obtained using chart review. Cases were segregated according to the adequacy …

Malemedicine.medical_specialtymedicine.drug_classUrinary systemAntibioticsComorbiditySeverity of Illness Indexlaw.inventionHospitals UniversityDrug TherapylawInternal medicineInternal MedicinemedicineHumansHospital MortalityRisk factorIntensive care medicineAPACHEAgedRetrospective StudiesAged 80 and overAPACHE IIbusiness.industryMortality rateOdds ratioLength of Staymedicine.diseasePrognosisIntensive care unitAnti-Bacterial AgentsCross-Sectional StudiesTreatment OutcomeBacteremiaUrinary Tract InfectionsFemalebusinessEuropean journal of internal medicine
researchProduct

Prevention and treatment of cystitis during menopause: efficacy of a nutraceutical containing D-mannose, inulin, cranberry, bearberry, Olea europaea,…

2020

Aim of the study: To evaluate the efficacy of a nutraceutical compound containing Uticlin® (D-mannose, cranberry, bearberry, Olea europaea), inulin, Orthosiphon and Lactobacillus acidophilus, in preventing recurrent urinary tract infections (UTIs) in menopausal women. Material and methods: This was a prospective cohort study of menopausal women recruited with a history of recurrent UTIs in the previous twelve months and who intended to treat their bladder problem without the use of antibiotics and/or anti-inflammatories. Women were proposed the use of an oral nutraceutical compound. The drug was taken for ten days, every month. Women were assigned to two parallel cohorts: patients using (gr…

medicine.medical_specialtymedicine.drug_classVisual analogue scaleEndocrinology Diabetes and MetabolismUrinary systemCystitiAntibioticsmenopaused-mannoseGastroenterology03 medical and health sciences0302 clinical medicineLactobacillus acidophilusNutraceuticalInternal medicinemedicineutisProspective cohort studycystitisUrinary tract infection030219 obstetrics & reproductive medicineOrthosiphonbiologybusiness.industryRObstetrics and Gynecologybiology.organism_classificationmedicine.diseasenutraceutical.MenopauseMedicineNutraceuticalurinary tract infectionsbusinessMenopausal Review
researchProduct

Urinary tract infections in children: EAU/ESPU guidelines.

2015

Context: In 30% of children with urinary tract anomalies, urinary tract infection (UTI) can be the first sign. Failure to identify patients at risk can result in damage to the upper urinary tract.Objective: To provide recommendations for the diagnosis, treatment, and imaging of children presenting with UTI.Evidence acquisition: The recommendations were developed after a review of the literature and a search of PubMed and Embase. A consensus decision was adopted when evidence was low.Evidence synthesis: UTIs are classified according to site, episode, symptoms, and complicating factors. For acute treatment, site and severity are the most important. Urine sampling by suprapubic aspiration or c…

Maleurologic and male genital diseasesPediatricsSeverity of Illness IndexESPUVOIDING CYSTOURETHROGRAPHYFollow-up imagingSuprapubic aspirationRisk FactorsDiagnosisguidelinesAntibiotic prophylaxisChildChildrenObstructive uropathyUpper urinary tractUrinary tract infectionDiagnostic Techniques Urologicalfemale genital diseases and pregnancy complicationsAnti-Bacterial AgentsTreatment OutcomeEAUAntibacterial treatmentUrinary Tract InfectionsFemalePRIMARY VESICOURETERAL REFLUXmedicine.symptomYOUNG-CHILDRENmedicine.medical_specialtyUrologyRenal scarUrologyBacteriuriaCONTROLLED-TRIALSUPRAPUBIC ASPIRATIONVesicoureteral reflux1ST FEBRILE UTIANTIBIOTIC-PROPHYLAXISPredictive Value of TestsUrine samplingInternal medicineUltrasoundmedicineHumansTRANSABDOMINAL ULTRASOUNDACUTE PYELONEPHRITISbusiness.industryInfant NewbornInfantmedicine.diseasePyuriaTreatmentLeukocyte esteraseFOLLOW-UPbusinessEuropean urology
researchProduct

Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic an…

2016

Objectives: We utilized the database of the Defining Antibiotic Levels in Intensive care unit patients (DALI) study to statistically compare the pharmacokinetic/pharmacodynamic and clinical outcomes between prolonged- infusion and intermittent-bolus dosing of piperacillin/tazobactam and meropenem in critically ill patients using inclusion criteria similar to those used in previous prospective studies. Methods: This was a post hoc analysis of a prospective, multicentre pharmacokinetic point-prevalence study (DALI), which recruited a large cohort of critically ill patients from 68 ICUs across 10 countries. Results: Of the 211 patients receiving piperacillin/tazobactam and meropenem in the DAL…

0301 basic medicineMalePenicillanic Acidintensive care unitlaw.inventionthienamycin derivative abdominal infection[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseaseslawcentral nervous system infectioncreatinine clearancePharmacology (medical)Infusions IntravenouProspective StudiesInfusions IntravenousProspective cohort studyTazobactam Drug CombinationAged; Anti-Bacterial Agents; Blood Chemical Analysis; Critical Illness; Female; Humans; Infusions Intravenous; Intensive Care Units; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin Tazobactam Drug Combination; Prospective Studies; Thienamycins; Treatment Outcome; Pharmacology; Microbiology (medical); Pharmacology (medical); Infectious Diseasescritical illneMicrobial Sensitivity TestadultRespiratory infectionclinical trialMiddle Agedcontinuous infusionanalogs and derivativeIntensive care unit3. Good healthAnti-Bacterial Agentsantiinfective agentintravenous drug administrationIntensive Care Units[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologyTreatment OutcomeInfectious DiseasesPiperacillin/tazobactammulticenter study (topic)SOFA scoreFemaletreatment outcome AgedIntravenousprospective studyHumanmedicine.drugsurvival rateMicrobiology (medical)medicine.medical_specialtyInfusionspost hoc analysirespiratory tract infectionCritical IllnessAged; Anti-Bacterial Agents; Blood Chemical Analysis; Critical Illness; Female; Humans; Infusions Intravenous; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Prospective Studies; Thienamycins; Treatment Outcome; Pharmacology; Pharmacology (medical); Infectious Diseases030106 microbiologybloodstream infectionMicrobial Sensitivity Testsminimum inhibitory concentrationpiperacillin plus tazobactamMeropenemTazobactamArticle03 medical and health sciencescritically ill patientInternal medicineAnti-Bacterial AgentmedicineSequential Organ Failure Assessment ScoreHumansThienamycinsurvival timeblood analysiAgedPiperacillinPharmacologybusiness.industryBlood Chemical AnalysiMeropenemmajor clinical studySurgeryProspective Studiemulticenter studyPharmacology; Pharmacology (medical); Infectious Diseases[SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/PharmacologyThienamycinspiperacillin tazobactam drug combinationurinary tract infectionbusinessBlood Chemical AnalysisPiperacillin
researchProduct

Escherichia coli of human and avian origin: detection of clonal groups associated with fluoroquinolone and multidrug resistance in Italy

2012

Objectives: Poultry have been suggested as a reservoir for fluoroquinolone-resistant extraintestinal pathogenic Escherichia coli (ExPEC). Our aim was to investigate whether genotypes associated with ciprofloxacin and multidrug resistance were shared among human and avian E. coli. Methods: We compared 277 human ExPEC isolates from urinary tract infection (UTI) and sepsis (142 susceptible and 135 ciprofloxacin resistant) and 101 avian isolates (68 susceptible and 33 ciprofloxacin resistant) by antimicrobial resistance phenotype, phylogenetic group and multilocus sequence type (ST). Results: Most ciprofloxacin-resistant isolates from both human and avian sources were multidrug resistant. Human…

MaleMicrobiology (medical)TurkeysSettore MED/07 - Microbiologia E Microbiologia ClinicaAdolescentGenotypeBiologymedicine.disease_causeGroup AMicrobiologyAntibiotic resistanceDrug Resistance Multiple BacterialSepsisGenotypeEscherichia colimedicineAnimalsCluster AnalysisHumansPharmacology (medical)zoonosis urinary tract infections MLST molecular epidemiologyChildEscherichia coliEscherichia coli InfectionsPoultry DiseasesPharmacologyExtraintestinal Pathogenic Escherichia coliPhylogenetic treeInfantVirologyDrug Resistance MultipleAnti-Bacterial AgentsCiprofloxacinMultiple drug resistanceInfectious DiseasesItalyChild PreschoolUrinary Tract InfectionsFemaleChickensFluoroquinolonesMultilocus Sequence Typingmedicine.drug
researchProduct

Regulation of type 1 fimbriae synthesis and biofilm formation by the transcriptional regulator LrhA of Escherichia coli

2005

Type 1 fimbriae ofEscherichia colifacilitate attachment to the host mucosa and promote biofilm formation on abiotic surfaces. The transcriptional regulator LrhA, which is known as a repressor of flagellar, motility and chemotaxis genes, regulates biofilm formation and expression of type 1 fimbriae. Whole-genome expression profiling revealed that inactivation oflrhAresults in an increased expression of structural components of type 1 fimbriae.In vitro, LrhA bound to the promoter regions of the twofimrecombinases (FimB and FimE) that catalyse the inversion of thefimApromoter, and to the invertible element itself. TranslationallacZfusions with these genes and quantification offimEtranscript le…

urinary-tractphase variationFimbrialac operonRepressorsuicide vectorBiologyFlagellummedicine.disease_causeMicrobiologyBacterial AdhesionMicrobiologylysr homologMiceglobal regulatorh-nsEscherichia colimedicineAnimalsHumansgenetic-analysisPromoter Regions GeneticEscherichia coliEscherichia coli InfectionsOligonucleotide Array Sequence AnalysisPhase variationRegulation of gene expressionfim switchEscherichia coli ProteinsGene Expression ProfilingBiofilmGene Expression Regulation Bacterialbiochemical phenomena metabolism and nutritionintegration host factorBiofilmsFimbriae BacterialMutationUrinary Tract Infectionsvirulence determinantsTranscription Factors
researchProduct